|
|
Volumn 21, Issue 3, 2006, Pages 828-829
|
|
Lamivudine and HBV-associated nephropathy [16]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ADULT;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
LETTER;
LIVER BIOPSY;
LIVER FUNCTION TEST;
MALE;
MEMBRANOUS GLOMERULONEPHRITIS;
PRIORITY JOURNAL;
PROTEINURIA;
REMISSION;
UNSPECIFIED SIDE EFFECT;
CHILD;
CHILD, PRESCHOOL;
DNA, VIRAL;
FEMALE;
GLOMERULONEPHRITIS, MEMBRANOUS;
HEPADNAVIRIDAE INFECTIONS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
|
|
EID: 33644868164
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfi239 Document Type: Letter |
|
Times cited : (11)
|
|
References (6)
|
